UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:October 28,
RespireRx Pharmaceuticals (PK) (USOTC:RSPI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more RespireRx Pharmaceuticals (PK) Charts.
RespireRx Pharmaceuticals (PK) (USOTC:RSPI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more RespireRx Pharmaceuticals (PK) Charts.

Respirerx Pharmaceuticals Inc. News

Form 8-K - Current report
Friday 2 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 22 January 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 11 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 17 November 2023 (5 months ago) • Edgar (US Regulatory)
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Tuesday 14 November 2023 (6 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 12 October 2023 (7 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 2 October 2023 (7 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 21 August 2023 (8 months ago) • Edgar (US Regulatory)
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Monday 14 August 2023 (9 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 9 August 2023 (9 months ago) • Edgar (US Regulatory)

More Respirerx Pharmaceuticals Inc. News Articles